Literature DB >> 15197438

Noninvasive vs invasive ventilation in COPD patients with severe acute respiratory failure deemed to require ventilatory assistance.

Enzo Squadrone1, Pamela Frigerio, Claudio Fogliati, Cesare Gregoretti, Giorgio Conti, Massimo Antonelli, Roberta Costa, Paola Baiardi, Paolo Navalesi.   

Abstract

OBJECTIVE: To determine whether non-invasive ventilation (NIV) may be an effective and safe alternative to invasive mechanical ventilation in chronic obstructive pulmonary disease (COPD) patients with acute respiratory failure (ARF) meeting criteria for mechanical ventilation. DESIGN AND
SETTING: Matched case-control study conducted in ICU. PATIENTS AND INTERVENTION: NIV was prospectively applied to 64 COPD patients with advanced ARF. Their outcomes were compared with those of a control group of 64 COPD patients matched on age, FEV(1), Simplified Acute Physiology Score II, and pH at ICU admission, previously treated in the same ICU with conventional invasive mechanical ventilation. METHODS AND
RESULTS: NIV failed in 40 patients who required intubation. Mortality rate, duration of mechanical ventilation, and lengths of ICU and post-ICU stay were not different between the two groups. The NIV group had fewer complications ( P = 0.01) and showed a trend toward a lower proportion of patients remaining on mechanical ventilation after 30 days ( P = 0.056). Compared to the control group, the outcomes of the patients who failed NIV were no different. Compared to the patients who received intubation, those who succeeded NIV had reduced mortality rate and lengths of ICU and post-ICU stay.
CONCLUSIONS: In COPD patients with advanced hypercapnic acute respiratory failure, NIV had a high rate of failure, but, nevertheless, provided some advantages, compared to conventional invasive ventilation. Subgroup analysis suggested that the delay in intubation was not deleterious in the patients who failed NIV, whereas a better outcome was confirmed for the patients who avoided intubation.

Entities:  

Mesh:

Year:  2004        PMID: 15197438     DOI: 10.1007/s00134-004-2320-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  33 in total

Review 1.  International Consensus Conferences in Intensive Care Medicine: non-invasive positive pressure ventilation in acute respiratory failure. Organised jointly by the American Thoracic Society, the European Respiratory Society, the European Society of Intensive Care Medicine, and the Société de Réanimation de Langue Française, and approved by the ATS Board of Directors, December 2000.

Authors:  T W Evans
Journal:  Intensive Care Med       Date:  2001-01       Impact factor: 17.440

2.  Randomized, controlled trials, observational studies, and the hierarchy of research designs.

Authors:  J Concato; N Shah; R I Horwitz
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

3.  Predictors of outcome for patients with COPD requiring invasive mechanical ventilation.

Authors:  M L Nevins; S K Epstein
Journal:  Chest       Date:  2001-06       Impact factor: 9.410

4.  Noninvasive ventilation for treatment of acute respiratory failure in patients undergoing solid organ transplantation: a randomized trial.

Authors:  M Antonelli; G Conti; M Bufi; M G Costa; A Lappa; M Rocco; A Gasparetto; G U Meduri
Journal:  JAMA       Date:  2000-01-12       Impact factor: 56.272

5.  Association of noninvasive ventilation with nosocomial infections and survival in critically ill patients.

Authors:  E Girou; F Schortgen; C Delclaux; C Brun-Buisson; F Blot; Y Lefort; F Lemaire; L Brochard
Journal:  JAMA       Date:  2000-11-08       Impact factor: 56.272

6.  A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure.

Authors:  M Antonelli; G Conti; M Rocco; M Bufi; R A De Blasi; G Vivino; A Gasparetto; G U Meduri
Journal:  N Engl J Med       Date:  1998-08-13       Impact factor: 91.245

7.  Randomized versus historical controls for clinical trials.

Authors:  H Sacks; T C Chalmers; H Smith
Journal:  Am J Med       Date:  1982-02       Impact factor: 4.965

8.  Noninvasive mechanical ventilation via face mask in patients with acute respiratory failure who refused endotracheal intubation.

Authors:  G U Meduri; R C Fox; N Abou-Shala; K V Leeper; R G Wunderink
Journal:  Crit Care Med       Date:  1994-10       Impact factor: 7.598

9.  Randomized, prospective trial of noninvasive positive pressure ventilation in acute respiratory failure.

Authors:  N Kramer; T J Meyer; J Meharg; R D Cece; N S Hill
Journal:  Am J Respir Crit Care Med       Date:  1995-06       Impact factor: 21.405

10.  Noninvasive positive pressure ventilation via face mask. First-line intervention in patients with acute hypercapnic and hypoxemic respiratory failure.

Authors:  G U Meduri; R E Turner; N Abou-Shala; R Wunderink; E Tolley
Journal:  Chest       Date:  1996-01       Impact factor: 9.410

View more
  44 in total

1.  From belief to knowledge: call it evidence if you prefer.

Authors:  Paolo Navalesi; Massimo Antonelli; Giorgio Conti
Journal:  Intensive Care Med       Date:  2010-11-10       Impact factor: 17.440

2.  Noninvasive ventilation through a helmet in postextubation hypoxemic patients: physiologic comparison between neurally adjusted ventilatory assist and pressure support ventilation.

Authors:  Gianmaria Cammarota; Carlo Olivieri; Roberta Costa; Rosanna Vaschetto; Davide Colombo; Emilia Turucz; Federico Longhini; Francesco Della Corte; Giorgio Conti; Paolo Navalesi
Journal:  Intensive Care Med       Date:  2011-10-18       Impact factor: 17.440

Review 3.  [Hypercapnic respiratory failure. Pathophysiology, indications for mechanical ventilation and management].

Authors:  U Kreppein; P Litterst; M Westhoff
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-02-22       Impact factor: 0.840

Review 4.  [Update: acute hypercapnic respiratory failure].

Authors:  F Seiler; F C Trudzinski; M Kredel; C Lotz; P M Lepper; R M Muellenbach
Journal:  Med Klin Intensivmed Notfmed       Date:  2017-07-13       Impact factor: 0.840

5.  Relationship between intubation rate and continuous positive airway pressure therapy in the prehospital setting.

Authors:  Nigel Knox; Ogedegbe Chinwe; Nyirenda Themba; Feldman Joseph; Ashtyani Hormoz
Journal:  World J Emerg Med       Date:  2015

6.  Benefits and risks of success or failure of noninvasive ventilation.

Authors:  Alexandre Demoule; Emmanuelle Girou; Jean-Christophe Richard; Solenne Taille; Laurent Brochard
Journal:  Intensive Care Med       Date:  2006-09-21       Impact factor: 17.440

7.  Noninvasive ventilation in hypercapnic acute respiratory failure due to chronic obstructive pulmonary disease vs. other conditions: effectiveness and predictors of failure.

Authors:  Jason Phua; Kien Kong; Kang Hoe Lee; Liang Shen; T K Lim
Journal:  Intensive Care Med       Date:  2005-03-02       Impact factor: 17.440

8.  Noninvasive versus conventional ventilation to treat hypercapnic encephalopathy in chronic obstructive pulmonary disease.

Authors:  Raffaele Scala; Stefano Nava; Giorgio Conti; Massimo Antonelli; Mario Naldi; Ivano Archinucci; Giovanni Coniglio; Nicholas S Hill
Journal:  Intensive Care Med       Date:  2007-09-15       Impact factor: 17.440

9.  Early fiberoptic bronchoscopy during non-invasive ventilation in patients with decompensated chronic obstructive pulmonary disease due to community-acquired-pneumonia.

Authors:  Raffaele Scala; Mario Naldi; Uberto Maccari
Journal:  Crit Care       Date:  2010-04-29       Impact factor: 9.097

10.  The feasibility and safety of extracorporeal carbon dioxide removal to avoid intubation in patients with COPD unresponsive to noninvasive ventilation for acute hypercapnic respiratory failure (ECLAIR study): multicentre case-control study.

Authors:  Stephan Braune; Annekatrin Sieweke; Franz Brettner; Thomas Staudinger; Michael Joannidis; Serge Verbrugge; Daniel Frings; Axel Nierhaus; Karl Wegscheider; Stefan Kluge
Journal:  Intensive Care Med       Date:  2016-07-25       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.